Schedule 13G ownership disclosure

BIOCRYST PHARMACEUTICALS INC

Common Stock · CUSIP: 09058V103

Event date: 2025-03-31

Filing-level shares
17,483,490
Percent of class
8.4%
  • BlackRock, Inc.

    Shares: 17,483,490 · Class: 8.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001576419-25-000567
Form type
SCHEDULE 13G/A
Filer
BIOCRYST PHARMACEUTICALS INC
CIK
CIK 882796
Filed
Apr 17, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub